Captor Therapeutics Spolka Akcyjna

WSE:CTX Stock Report

Market Cap: zł210.8m

Captor Therapeutics Spolka Akcyjna Dividends and Buybacks

Dividend criteria checks 0/6

Captor Therapeutics Spolka Akcyjna does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-19.0%

Buyback Yield

Total Shareholder Yield-19.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Jul 13
Here's Why We're Not Too Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth

Mar 10
We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth

We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn

Oct 03
We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn

Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Mar 13
Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation

Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth

Jun 15
Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CTX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CTX's dividend payments have been increasing.


Dividend Yield vs Market

Captor Therapeutics Spolka Akcyjna Dividend Yield vs Market
How does CTX dividend yield compare to the market?
SegmentDividend Yield
Company (CTX)n/a
Market Bottom 25% (PL)3.0%
Market Top 25% (PL)8.2%
Industry Average (Biotechs)1.6%
Analyst forecast (CTX) (up to 3 years)n/a

Notable Dividend: Unable to evaluate CTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate CTX's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CTX has not reported any payouts.


Discover strong dividend paying companies